Factors Associated With the Decay of Anti-SARS-CoV-2 S1 IgG Antibodies Among Recipients of an Adenoviral Vector-Based AZD1222 and a Whole-Virion Inactivated BBV152 Vaccine

BackgroundThe magnitude of protection conferred following recovery from COVID-19 or by vaccine administration, and the duration of protective immunity developed, remains ambiguous.MethodsWe investigated the factors associated with anti-SARS-CoV-2 S1 IgG decay in 519 individuals who recovered from CO...

Descripció completa

Dades bibliogràfiques

Autors principals:	Sivaprakasam T. Selvavinayagam, Yean Kong Yong, Hong Yien Tan, Ying Zhang, Gurunathan Subramanian, Manivannan Rajeshkumar, Kalaivani Vasudevan, Priyanka Jayapal, Krishnasamy Narayanasamy, Dinesh Ramesh, Sampath Palani, Marie Larsson, Esaki M. Shankar, Sivadoss Raju
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-06-01
Col·lecció:	Frontiers in Medicine
Matèries:	AZD1222 BBV152 COVID-19 IgG decay SARS-CoV-2 vaccination
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fmed.2022.887974/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!